title: Vaccine-Induced Anti-HBs Level in 5-6 Year-Old Malnourished Children.
abstract: BACKGROUND
  Malnutrition is the most common cause of immune deficiency. It results in reduced secretion of T-cells and B-cell-stimulating factors leading to declining of special immunoglobulins. On the other hand, hepatitis B, as a major world health problem, can be prevented effectively by vaccination. Three doses of hepatitis B virus (HBV) vaccine induce protective levels of anti-hepatitis B surface (anti-HBs) in 95% of healthy children. This level decreases gradually over time.
  
  
  OBJECTIVE
  The goal of this study was to assess anti-HBs in malnourished children, who confronted to some degrees of immune deficiency.
  
  
  METHODS
  This is a cross-sectional study conducted during May to August 2010 in therapeutic clinics of Yazd, Iran. Samples were selected simply and consecutively among 5-6 year-old children with a history of three doses of HBV vaccine in infancy. On the basis of World Health Organization's definition on malnutrition, which considers anthropometric measurements, malnourished children entered the study. Totally 83 cases (37 boys and 46 girls) were gathered and classified into three groups of mild, moderate, and severe malnutrition. One milliliter of venous blood was taken and anti-HBs were tested by enzyme linked immunosorbant assay (ELISA).
  
  
  RESULTS
  Overall, seroprotection rate and geometric mean titer (GMT) of anti-HBs were 60.2% and 15.47 ± 10.92 mIU/mL, respectively. Seroprotection rate was 71.4%, 55.2%, and 72.7% in mild, moderate, and severe malnourished children, respectively. GMT was 30.78 mIU/mL, 12.15 mIU/mL, and 22.95 mIU/mL in these groups, respectively. None of these two indices were significant in these groups (P = 0.471, P = 0.364). Seroprotection rate and GMT were 54.1% and 13.26 ± 11.59 mIU/mL in boys, and 65.2% and 17.5 ± 10.59 mIU/mL in girls, respectively, showing no significant relationship with gender (P = 0.302, P = 0.602). Lowest seroprotection rate was in stunted cases (47.1%) and highest in wasted children (77.8%). This difference also was not significant (P = 0.43).
  
  
  CONCLUSIONS
  The seroprotection rate and GMT of anti-HBs observed in this study do not show a high level of immunity. These two indices were not related to severity of malnutrition. We conclude that severity of malnutrition does not affect vaccine-induced antibody level and seroprotection rate; however small sample size in each group of study hinders decisive conclusion. Moreover, GMT and seroprotection rate showed no relationship with type of abnormal anthropometric index, including weight for height, weight for age, and height for age.
authors: Children Growth Disorders Research Center, Shahid Sadoughi University of Medical Science, Yazd, IR Iran.
authors: Mehran
authors: M
authors: Karimi
authors: Ali
authors: A
authors: Raee
authors: Behnam
authors: B
authors: Baghianimoghadam
authors: Mohammad Hossein
authors: MH
authors: Fallahzadeh
keywords: Children; Hepatitis B; Malnutrition; Vaccination
references: J Nutr. 2007 Mar;137(3):671-5
references: 17311958
references: ASAIO J. 2005 May-Jun;51(3):242-5
references: 15968954
references: J Natl Med Assoc. 2006 Dec;98(12):1953-7
references: 17225840
references: Vaccine. 1995 Jun;13(9):879
references: 7483812
references: Vaccine. 2004 Sep 28;22(29-30):3963-7
references: 15364445
references: Psychosom Med. 1992 Jan-Feb;54(1):22-9
references: 1553399
references: Aten Primaria. 1993 Apr;11(6):286-91
references: 8499534
references: Adv Perit Dial. 1996;12:315-7
references: 8865927
references: New Microbiol. 2003 Oct;26(4):311-9
references: 14596341
references: J Ayub Med Coll Abbottabad. 2006 Oct-Dec;18(4):4-9
references: 17591001
references: East Mediterr Health J. 2007 Sep-Oct;13(5):1031-42
references: 18290395
references: Am J Clin Nutr. 1976 Aug;29(8):836-41
references: 821332
references: Br J Nutr. 1982 Jul;48(1):7-14
references: 6809039
references: Clin Diagn Lab Immunol. 2005 Dec;12(12):1442-7
references: 16339069
references: PLoS One. 2012;7(5):e38153
references: 22666468
references: JAMA. 1985 Dec 13;254(22):3187-9
references: 2933532
references: World J Gastroenterol. 1998 Dec;4(6):493-496
references: 11819352
references: Obstet Gynecol. 1999 Jun;93(6):983-6
references: 10362167
references: Tissue Antigens. 1998 Jun;51(6):593-604
references: 9694351
references: J Med Virol. 1994 Oct;44(2):113-4
references: 7852951
references: Am J Clin Nutr. 1997 Aug;66(2):460S-463S
references: 9250133
references: N Z Med J. 1992 Aug 26;105(940):336-8
references: 1508451
references: Vaccine. 2006 May 15;24(20):4427-32
references: 16574284
references: J Clin Virol. 2006 May;36 Suppl 1:S45-50
references: 16831693
references: Environ Health Perspect. 2001 Aug;109(8):757-64
references: 11564609
references: Am J Epidemiol. 1996 Apr 1;143(7):718-24
references: 8651234
references: Am J Clin Nutr. 1974 Jun;27(6):638-46
references: 4208451
references: J Hepatol. 2007 Jun;46(6):1018-25
references: 17399842
references: Pediatr Infect Dis J. 2003 Feb;22(2):157-63
references: 12586980
references: Vaccine. 1996 Aug;14(11):1019-27
references: 8879096
references: Vaccine. 1993;11(10):1033-6
references: 8212823
references: Am J Kidney Dis. 1997 Feb;29(2):239-45
references: 9016896
references: J Nutr. 2003 Jan;133(1):336S-340S
references: 12514322
references: J Trop Pediatr. 1996 Jun;42(3):144-5
references: 8699579
references: Int J Epidemiol. 2003 Aug;32(4):518-26
references: 12913022
references: Am J Kidney Dis. 2003 Dec;42(6):1184-92
references: 14655190
references: Drugs. 2003;63(10):1021-51
references: 12699402